E- Poster / 編號
2026PE-B17
Category / 徵稿主題
07 臨床藥學類：藥物流行病學、藥物安全、藥物經濟學、健保藥價政策
Title / 題目
Cost-effectiveness of Denosumab versus Alendronate for Primary Fracture Prevention in Insulin-Treated Patients with Diabetes and Osteoporosis in Taiwan
Author / 作者群
全家甫1,呂元嘉1
Affiliation / 服務單位
1. Pharmacy Division, En Chu Kong Hospital, New Taipei City, Taiwan